TTM
−$0.26
YoY change
+466.0%
5Y CAGR
—
Peak year (2014)
$2.34
Latest annual
−$3.00
EPS (Diluted) history chart for Viatris (VTRS) from 2003 to 2025
Latest: −$3.00
EPS (Diluted) growth chart for Viatris (VTRS) from 2003 to 2025
Latest: +466.0%
EPS (Diluted) history table for Viatris (VTRS) from 2003 to 2025
| 2025 | −$3.00 | +466.0% | −$2.47 | ||
| 2024 | −$0.53 | -1270.0% | −$0.58 | ||
| 2023 | $0.05 | -97.4% | −$1.66 | ||
| 2022 | $1.71 | -262.9% | +$2.76 | ||
| 2021 | −$1.05 | -5.4% | +$0.06 | ||
| 2020 | −$1.11 | -3800.0% | −$1.14 | ||
| 2019 | $0.03 | -95.6% | −$0.65 | ||
| 2018 | $0.68 | -47.7% | −$0.62 | ||
| 2017 | $1.30 | +41.3% | +$0.38 | ||
| 2016 | $0.92 | -45.9% | −$0.78 | ||
| 2015 | $1.70 | -27.4% | −$0.64 | ||
| 2014 | $2.34 | +48.1% | +$0.76 | ||
| 2013 | $1.58 | +3.9% | +$0.06 | ||
| 2012 | $1.52 | +24.6% | +$0.30 | ||
| 2011 | $1.22 | +79.4% | +$0.54 | ||
| 2010 | $0.68 | +126.7% | +$0.38 | ||
| 2009 | $0.30 | -146.9% | +$0.94 | ||
| 2008 | −$0.64 | -89.2% | +$5.26 | ||
| 2007 | −$5.90 | — | — | ||
| 2005 | $0.79 | +6.8% | +$0.05 | ||
| 2004 | $0.74 | -38.8% | −$0.47 | ||
| 2003 | $1.21 | — | — |
- 2025−$3.00+466.0%
- 2024−$0.53-1270.0%
- 2023$0.05-97.4%
- 2022$1.71-262.9%
- 2021−$1.05-5.4%
- 2020−$1.11-3800.0%
- 2019$0.03-95.6%
- 2018$0.68-47.7%
- 2017$1.30+41.3%
- 2016$0.92-45.9%
- 2015$1.70-27.4%
- 2014$2.34+48.1%
- 2013$1.58+3.9%
- 2012$1.52+24.6%
- 2011$1.22+79.4%
- 2010$0.68+126.7%
- 2009$0.30-146.9%
- 2008−$0.64-89.2%
- 2007−$5.90—
- 2005$0.79+6.8%
- 2004$0.74-38.8%
- 2003$1.21—
EPS (Diluted) values are taken from Viatris's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EPS (Diluted) at Viatris (VTRS)
According to Viatris's latest reported financial statements, the company's current diluted EPS (TTM) is −$0.26. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Viatris (VTRS) reported diluted EPS of −$3.00 – surged 466.0% year-over-year.
Viatris diluted EPS plunged from $2.34 in 2014 to −$3.00 in 2025, a 228.2% drawdown.
The highest annual diluted EPS of $2.34 was reported in 2014. The lowest in the available history was −$5.90 in 2007.
Viatris EPS (Diluted) by Year
Viatris EPS (Diluted) 2025: −$3.00
2025's diluted EPS for Viatris came in at −$3.00, surged 466.0% from 2024.
Viatris EPS (Diluted) 2024: −$0.53
Viatris posted diluted EPS of −$0.53 in 2024, plunged 1270.0% below 2023.
Viatris EPS (Diluted) 2023: $0.05
In 2023, Viatris reported diluted EPS of $0.05, plunged 97.4% below 2022.
Viatris EPS (Diluted) 2022: $1.71
Viatris diluted EPS in 2022 was $1.71, plunged 262.9% below 2021.
Viatris EPS (Diluted) 2021: −$1.05
Viatris diluted EPS in 2021 was −$1.05.
See more financial history for Viatris (VTRS). Or calculate EPS yourself.
Sector peers by EPS (Diluted)
Healthcare peers of Viatris (VTRS), ranked by their latest diluted EPS
| $22.95 | |
| $14.23 | |
| $13.23 | |
| $11.03 | |
| $7.28 | |
| $6.54 | |
| $3.59 | |
| $2.37 |
- $22.95
- $14.23
- $13.23
- $11.03
- $7.28
- $6.54
- $3.59
- $2.37
Frequently asked questions
Viatris (VTRS) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation